Prevalence Of Psychological Comorbidities Research Articles

Pendampingan Bubble Wrap Exercise Therapy Pada Pasien dengan Distress Diabetes di Wahana Cipta Sinatria Karanganyar

The prevalence of psychological comorbidities in people with diabetes worldwide is nearly a quarter of people suffer from symptoms of depression or diabetes distress. Management to reduce a person's stress level based on several studies entitled Popping Sealed Air Capsules to Reduce Stress by Dillon KM. The purpose of this service is according to the Bubble Wrap Therapy Training is expected to reduce stress in patients with DM. The method used is a demonstration of bubble wrap exercise training for 15 minutes each part of the feet and hands by pressing bubble wrap using feet and hands and providing health education for 30 minutes on the importance of controlling stress levels in patients with DM. The results of the service show the level of stress with the results of BWET AD ACL from moderate stress level 68.75%, to mild 56.25%. Conclusion Bubble wrap therapy training effectively reduces the level of diabetic distress at Wahana Cipta Sinatria Karanganyar.

Prevalence of psychological comorbidities in bone infection

ObjectiveBone infections represent a major complication in orthopedic and trauma surgery. Concomitant psychological disorders can significantly influence treatment outcomes. However, these are often overlooked. Therefore, we aimed to determine the nationwide epidemiology of fracture-related infection (FRI) and osteomyelitis in combination with psychological comorbidities. MethodsA dataset provided by the Federal Statistical Office (Destatis) consisting of annual, Germany-wide ICD-10 diagnosis codes from 2009 to 2019 was analysed. Incidences of the codes “T84.6, infection and inflammatory reaction due to internal fixation device” and “M86.-, osteomyelitis” were quantified. Proportions of secondary diagnoses of the chapter F of the ICD-10 were determined. ResultsIncidences were 19.1/100,000 inhabitants for osteomyelitis and 10.5/100,000 inhabitants for FRI. Patients with psychological comorbidities constituted 14.6% of osteomyelitis cases and 26.5% of FRI cases, respectively. Between 2009 through 2019, the proportion of patients with a concomitant “F” diagnoses of the ICD-10 increased by 27.3% for osteomyelitis and by 24.1% for FRI. Most prevalent secondary diagnoses were organic, including symptomatic, mental disorders (F0), affective disorder (F3) and mental and behavioral disorders due to psychoactive substance use (F1), whereby the latter decreased over the years. ConclusionThe implementation of prevention strategies, interdisciplinary approaches and psychological support in orthopaedics and trauma surgery is warranted.

Psychiatric Co-Morbidity and Substance Use Correlated with Medication Adherence Among People Living with HIV (PLWHIV) Attending the Virology Clinic of the University of Port Harcourt Teaching Hospital (UPTH)

HIV infection is an endemic communicable chronic disease, of enormous public health concern worldwide particularly, Sub-Saharan African. Substance use and associated psychiatric co-morbidity among the sufferers may affect medication adherence. The aim of this study, therefore, was to determine the effect of psychiatric comorbidity and substance use on medication adherence among people living with HIV at the University of Port Harcourt Teaching Hospital. A cross-sectional study was conducted among 230 Subjects Living with HIV. Sociodemographic questionnaire was used. A structured questionnaire was used to assess use of psychoactive substances. Psychiatric co-morbidity was assessed using the GHQ-12 in conjunction with the DSM 5. The Medication Adherence Rating Scale (MARS) was used to assess medication adherence. Data was analysed using the SPSS version 20. The prevalence of psychological co-morbidity among PLWHIV was 30.6%. Alcohol use disorders was the highest with 73 (31.7%), followed by cigarette smoking 38 (16.5%) while nicotine snuffing was the least with 1 (0.4%). Of the 43 (18.7%) with poor medication adherence, 31 (15.2%) had psychiatric co-morbidity, 26 (11.3%) had substance use, 25 (10.8%) had both psychiatric and substance use co-morbidity while 19 (8.2%) had none (p=0.004). Psychological co-morbidity and substance use are prevalent among PLWHIV, and may affect medication adherence.

Prevalence of Psychological Co-morbidities among medical and dental students of a Medical University of Nepal

Introduction: Medical and Dental students are vulnerable to higher levels of Psychological distress than other age matched peers. This study was carried to identify prevalence of depression and anxiety in medical and dental students. 
 Material and Method: A cross sectional study was done among medical and dental students (2nd year to interns) of BPKIHS. A total of 600 students were enrolled through systematic random sampling and 588 (98%) responded. Semi-structured questionnaire was used to record socio-demographic variables along with Becks Depression Inventory(BDI) and Becks Anxiety Inventory(BAI). 
 Results: The mean age of participants was 22±2years among which 61.2%(360) were male, 69.7%(410) were from medical faculty, 90.5%(532) were Nepalese and 9.5%(56) were Indians. Depressive symptoms was recorded in 25.3%(149) out of which 12.6%(74), 6.5%(38), 5.3%(31), 0.5%(3), 0.5%(3) had mild, borderline, moderate, severe and extreme depressive symptoms respectively. Similarly anxiety was recorded among 7.8%(46) students with 42 having moderate and 4 having severe anxiety symptoms. Among the participants 6.3%(37) had suicidal thoughts and 4(0.7%) of them had suicide attempt in last one year. 
 Conclusion: Medical and dental students showed high prevalence of anxiety and depression even with suicidal thoughts including past attempt.

The prevalence of psychological comorbidity in people with vitiligo: a systematic review and meta-analysis.

Vitiligo is a chronic disorder causing skin depigmentation with global prevalence varying from 0·2% to 1·8%. U.K. guidelines recommend assessment of psychological state during clinical evaluation of vitiligo. However, the prevalence of psychological comorbidity in people with vitiligo has not been described. To establish the prevalence of psychological symptoms or disorders in people with vitiligo and describe the outcome measures used. We performed a comprehensive search of MEDLINE, Embase, CINAHL and PsycINFO to identify observational studies assessing the prevalence of psychological symptoms or disorders (December 2016). DerSimonian and Lard random-effects models were used to estimate the overall pooled prevalence. We identified 29 studies with 2530 people with vitiligo. Most studies included a measure of either depression (n=25) or anxiety (n=13). The commonest tools were the Hospital Anxiety and Depression Scale and the Centre for Epidemiology Studies Depression Scale. Ten studies provided information on 13 other psychological outcomes. Pooled prevalence using depression-specific and anxiety-specific questionnaires was 0·29 [95% confidence interval (CI) 0·21-0·38] and 0·33 (95% CI 0·18-0·49), respectively. Prevalence was lower for clinically diagnosed depression (0·21, 95% CI 0·15-0·28) and anxiety (0·15, 95% CI 0·06-0·24). When nonspecific tools were used the prevalence remained similar for depression (0·27, 95% CI 0·08-0·46) but increased for anxiety (0·46, 95% CI 0·39-0·52). High heterogeneity was observed. A range of psychological outcomes are common in people with vitiligo. The prevalence of anxiety was influenced by type of screening tool, suggesting the need for validation of psychological outcome screening tools in the field of dermatology.

The prevalence of psychological comorbidity in people with vitiligo: a systematic review and meta-analysis

Summary Vitiligo is a long-term condition where pale white patches develop on the skin. It's caused by a lack of melanin, a pigment (colour) in the skin. People of any age, skin type and gender can develop vitiligo and it can affect any area of skin. It is estimated that about 1 in 100 people around the world has vitiligo. The researchers who conducted this study are based in Nigeria and the UK. Our study aimed to find out how commonly psychological symptoms such as depression and anxiety occur in people in vitiligo, by looking at all relevant published studies from around the world. After extracting data from 29 studies published in this area we found that people living with vitiligo experience a range of psychological symptoms or disorders. Approximately one in four people with vitiligo appear to have depression and at least one in seven have anxiety. However, they were significantly less likely to show symptoms of depression than people with psoriasis. We also found that there were many tools to measure psychological outcomes (the emotional impact) in skin diseases, and more work needs to be done to develop tools which can be used in people with vitiligo. Our conclusion is that assessment of psychological state during clinical evaluation of vitiligo patients, as suggested by the British Association of Dermatologists’ guidelines, is essential. The same can be said for clinical evaluation of people with other skin conditions.

Psychological comorbidities and compliance to interventional treatment of patients with cutaneous vascular malformations.

The aim of this study was to assess qualitatively the psychological stressors affecting patients with cutaneous vascular malformations and hemangiomas (CVM-H) and their impact on compliance to interventional treatment. A retrospective chart review was conducted of all patients with CVM-H treated by interventional neuroradiology at a single academic institution during a five-year period (2009-2014). Psychological complaints were documented during each clinic visit by a neuroradiologist. Compliance to interventional treatment was defined by adherence to the scheduled treatment sessions. Fisher's exact test was used to assess for associations between psychological complaints and compliance. Seventy-five patients were assessed, of whom 49 (65.3%) were female, with an age range of 2-78 years (mean age 30.2 years). All except one patient older than seven years of age (n = 71; 94.6%) had a psychological complaint, including fear of negative appearance (n = 53; 70.6%), dissatisfaction with appearance (n = 46; 61.3%), low self-esteem (n = 35; 46.6%), anxiety (n = 16; 21.3%), stress (n = 13; 17.3%), bullying (n = 5; 6.6%), and low mood (n = 4; 5.3%). Twenty-three (31%) patients were non-compliant. Low self-esteem was significantly associated with non-compliance (p = 0.0381). There is a high prevalence of psychological comorbidities among patients treated for CVM-H. This has potential implications for interventional treatment, as it was found that low self-esteem is significantly associated with non-compliance. These results suggest the need for early psychological support in these patients in order to maximize compliance to interventional treatment.

Social Competence in Children with Neurofibromatosis Type 1: Relationships with Psychopathology and Cognitive Ability

Background: Neurofibromatosis type 1 (NF1) is a neurodevelopmental disorder associated with elevated risk of specific cognitive impairments and a high prevalence of psychological comorbidities. Children with NF1 have also been reported to display significant difficulties with peer relationships, although the exact nature of their social competence difficulties remains unclear. This study aimed to explore the nature of the day to day social competence difficulties observed in children with NF1 and to investigate how these difficulties might relate to cognitive dysfunction and symptoms of psychopathology. Methods and Findings: This study investigated parent ratings of day to day social competence in 23 children with neurofibromatosis type 1 (NF1) compared to 23 chronological age-matched typically developing controls using a brief, standardised questionnaire - the Social Competence with Peers Questionnaire. The relationships between social competence, psychopathology (parent ratings of Attention Deficit Hyperactivity Disorder or Autism Spectrum Disorder symptomatology), and cognitive ability (Full Scale IQ and parent ratings of functional executive behaviour) in children with NF1 were also explored using correlational analyses. Results indicated that children with NF1 displayed significantly poorer day to day social competence than controls. These social competence deficits were not related to Attention Deficit Hyperactivity Disorder symptomatology, Full Scale IQ or functional executive behaviour. However, difficulties with social competence were significantly related to Autism Spectrum Disorder symptomatology and socially anxious/avoidant behaviours in our NF1 cohort. Conclusions: These results indicate that children with NF1 are at significant risk of day to day social competence difficulties, especially those who display high levels of autistic symptomatology and socially anxious behaviour. Our findings suggest a need to incorporate screening for social competence problems and comorbid psychopathology into the more general clinical management of children with NF1.

Anxiety, depression and hyperventilation symptoms in treatment‐resistant severe asthma

Background Psychological morbidity is associated with frequent asthma exacerbations, higher health care utilization, as well as near-fatal and fatal asthma. The prevalence of psychological comorbidities in patients with severe asthma is not well-studied. The aim of our study was to evaluate the prevalence of anxiety, depression and hyperventilation, and correlate these symptoms with asthma control, exacerbation frequency and lung function in severe asthmatics.

Psychische Komorbidität

Psychosocial comorbidity in somatic disorders is considered an important problem from the epidemiological point of view as well as from the perspective of care. Therefore, the different origins or development are etiologically discussed. In this article, an overview of the prevalence of psychiatric comorbidity of musculoskeletal disorders, using chronic back pain in somatic medical rehabilitation as an example, is given. According to the statistics of the German pension insurance fund, musculoskeletal diseases are the most common indication. In this article, the opportunities and the challenges for medical rehabilitation in managing psychosocial comorbidity are discussed. Starting with the description of medical rehabilitation in Germany, the significance of psychosocial comorbidity in medical rehabilitation and the resulting opportunities arising from this special setting to screen for psychological comorbidity are examined. These aspects are discussed based on articles from 2000-2010 in the field of orthopedic inpatient medical rehabilitation. A total of ten studies, focusing on the medical rehabilitation of chronic back pain, were identified. It was found that three papers reported data on the prevalence of psychological comorbidity and addressed diagnostic screening. This is discussed from a perspective that addresses potential barriers on the part of therapists as well as the patients. More attention should be directed to implementing the appropriate screening and follow-up care.